Roche Archives

Tag: Roche

Obinutuzumab Showed Significantly Positive Results in Published Phase III Lupus Nephritis Study

Exciting breaking news: A paper published in the highly prestigious journal New England Journal of Medicine and presented at the World Congress of Nephrology reported that results of the Phase III REGENCY trial found that among people with active lupus nephritis, Gazyva® (obinutuzumab) plus standard therapy demonstrated statistically significant and clinically meaningful improvement in the […] Read More

The Lupus Research Alliance Teams Up with the New York Jets for New Jersey Walk with Us to Cure Lupus 20th Anniversary Event

EAST RUTHERFORD, NEW JERSEY. May 6, 2023. An enthusiastic crowd of nearly 1,500 supporters came together today at MetLife Stadium for the Lupus Research Alliance (LRA) 2023 New Jersey Walk with Us to Cure Lupus to raise nearly $500,000 for lupus research as well as public awareness of the serious and commonly misdiagnosed autoimmune disease. […] Read More

FDA Expedites Existing Drug Gazyva for Lupus Nephritis

September 18, 2019 The LRA is pleased to share that the U.S. Food and Drug Administration (FDA) granted Breakthrough Therapy Designation to obinutuzumab (Gazyva®) for adults with lupus nephritis – the most common complication of lupus. The FDA’s designation aims to speed up the development and review of drugs intended to treat a serious condition […] Read More